Please use this identifier to cite or link to this item:
|Title:||Arsenic trioxide in ovarian cancer||Authors:||ONG PEI SHI||Keywords:||Arsenic Trioxide; Ovarian cancer; Mitochondrial dysfunction; Caspase-independent cell death; Endoplasmic reticulum stress; glutathione||Issue Date:||14-Sep-2008||Citation:||ONG PEI SHI (2008-09-14). Arsenic trioxide in ovarian cancer. ScholarBank@NUS Repository.||Abstract:||Arsenic trioxide (As2O3) has shown anti-tumour activity against a variety of solid tumours in vitro. However, the mechanisms responsible for its cytotoxicity against ovarian carcinoma remain elusive. In this thesis, the molecular determinants of its effects and factors mediating its chemoresistance in ovarian cancer cells were investigated. It was found that As2O3 treatment caused both apoptosis induction and caspase-independent cell death involving mitochondrial dysfunction. This was accompanied by endoplasmic reticulum stress induction and an increase in intracellular glutathione (GSH) level. The latter was in turn prevented by the concurrent use of GSH modulator, buthionine sulfoximine but not ascorbic acid. Gene expression analysis of arsenic-resistant OVCAR-3 (OVCAR-3/AsR) cells showed the involvement of multiple factors mediating its chemoresistance. Of particular interest, a genetic hub involving elevated interleukin 1A signalling was identified. This could consecutively modulate the expression of other genes, thus promoting and ensuing the continual growth and survival of OVCAR-3/AsR cells.||URI:||http://scholarbank.nus.edu.sg/handle/10635/28135|
|Appears in Collections:||Ph.D Theses (Open)|
Show full item record
Files in This Item:
|Ong PSupdated.pdf||9.67 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.